Rahel Teferra, MD
Sleep Medicine · Louisville, KYNPI 1982862470
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $207 of the $245 with a category attached, or 84.5%. 5 manufacturers reported payments, led by Sanofi at 55.8% of the total. Reporting peaked in 2024 at $137 and has fallen 80.7% since, to $26 in 2025. That places this record below the midpoint for sleep medicine clinicians in KY, where the typical reported total is $1,510.
Across 7 payments — averaging $35.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$137
- Genentech USA, Inc.$51
- Inspire Medical Systems, Inc.$26
- Insmed, Inc.$18
- GSK$13
What the payments were for
- Food & beverage$20784%
- Education$3816%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 2 | $137 |
| Genentech USA, Inc. | 2 | $51 |
| Inspire Medical Systems, Inc. | 1 | $26 |
| Insmed, Inc. | 1 | $18 |
| GSK | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$129
How this compares
$245 in reported general payments places this provider in the 20th percentile of 28 sleep medicine providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 186 | $139,904 |
| Spiriva RespimatTiotropium Bromide | 56 | $41,780 |
| Breo ElliptaFluticasone/Vilanterol | 40 | $29,317 |
| SymbicortBudesonide/Formoterol Fumarate | 61 | $21,428 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 18 | $19,281 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 21 | $10,024 |
| Incruse ElliptaUmeclidinium Bromide | 25 | $8,829 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 11 | $8,647 |
| Arnuity ElliptaFluticasone Furoate | 28 | $7,725 |
| Ventolin HfaAlbuterol Sulfate | 42 | $4,242 |
| BreynaBudesonide/Formoterol Fumarate | 41 | $3,520 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 17 | $2,595 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 131 | $2,422 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 20 | $2,278 |
| Varenicline Tartrate | 14 | $2,108 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta, Anoro Ellipta, Arnuity Ellipta | $13 | $194,422290 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 20th percentile of 28 sleep medicine providers in Kentucky.
Other sleep medicine in Louisville
- Kevin TriceLouisville$220K
- William LacyLouisville$6K
- Robert KarmanLouisville$3K
- Egambaram SenthilvelLouisville$2K
- Juhee MianLouisville$2K
- Nicole ToddLouisville$2K
- Sarika ChandiramaniLouisville$2K
- Ammar AlmasalkhiLouisville$2K
- Warren ShaikunLouisville$1K
- Rajanna RamaswamyLouisville$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.